@misc{indiciae155355f837c8,
  title = {CerS2 is a druggable target in triple-negative breast cancer},
  author = {Alatawi, H. and Nair, H. H. and Ai, L. and Mahmud, I. and Gour, A. and Singh, A. and Baek, D. and Yan, B. and Maharjan, C. K. and Zhang, W. and Law, B. K. and Zajac-Kaye, M. and Vulpe, C. and Guryanova, O. A. and Sharma, A. K. and Garrett, T. J. and Sharma, A. and Heldermon, C. D. and Hong, S. and Narayan, S.},
  year = {2025},
  doi = {10.1101/2025.08.15.670525},
  url = {https://www.biorxiv.org/content/10.1101/2025.08.15.670525v1},
  note = {Source identifier: 10.1101/2025.08.15.670525}
}